237 related articles for article (PubMed ID: 17270148)
1. Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.
Schäfer A; Fraccarollo D; Vogt C; Flierl U; Hemberger M; Tas P; Ertl G; Bauersachs J
Biochem Pharmacol; 2007 May; 73(9):1367-75. PubMed ID: 17270148
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
Schäfer A; Fraccarollo D; Eigenthaler M; Tas P; Firnschild A; Frantz S; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus.
Schäfer A; Flierl U; Vogt C; Menninger S; Tas P; Ertl G; Bauersachs J
Pharmacol Res; 2007 Sep; 56(3):217-23. PubMed ID: 17669665
[TBL] [Abstract][Full Text] [Related]
4. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.
Schäfer A; Fraccarollo D; Pförtsch S; Flierl U; Vogt C; Pfrang J; Kobsar A; Renné T; Eigenthaler M; Ertl G; Bauersachs J
Br J Pharmacol; 2008 Mar; 153(5):886-93. PubMed ID: 17891166
[TBL] [Abstract][Full Text] [Related]
5. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
Schäfer A; Alp NJ; Cai S; Lygate CA; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1720-6. PubMed ID: 15242858
[TBL] [Abstract][Full Text] [Related]
6. Eplerenone improves vascular function and reduces platelet activation in diabetic rats.
Schafer A; Vogt C; Fraccarollo D; Widder J; Flierl U; Hildemann SK; Ertl G; Bauersachs J
J Physiol Pharmacol; 2010 Feb; 61(1):45-52. PubMed ID: 20228414
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.
Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R
Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361
[TBL] [Abstract][Full Text] [Related]
8. Effect of rosuvastatin on capillary filtration of albumin and blood pressure in rats with streptozotocin-induced diabetes.
Tarhzaoui K; Valensi P; Boulakia FC; Lestrade R; Albertini JP; Behar A
Diabetes Res Clin Pract; 2008 Jun; 80(3):335-43. PubMed ID: 18406000
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.
Kobayashi T; Matsumoto T; Kamata K
Br J Pharmacol; 2000 Sep; 131(2):231-8. PubMed ID: 10991915
[TBL] [Abstract][Full Text] [Related]
10. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Balaraman R
Life Sci; 2006 Apr; 78(22):2615-24. PubMed ID: 16318863
[TBL] [Abstract][Full Text] [Related]
11. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells.
Landsberger M; Jantzen F; Könemann S; Felix SB
Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose.
Piconi L; Corgnali M; Da Ros R; Assaloni R; Piliego T; Ceriello A
J Diabetes Complications; 2008; 22(1):38-45. PubMed ID: 18191076
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model.
Roan JN; Fang SY; Chang SW; Hsu CH; Huang CC; Chiou MH; Tsai YC; Lam CF
J Vasc Surg; 2012 Nov; 56(5):1381-9.e1. PubMed ID: 22727844
[TBL] [Abstract][Full Text] [Related]
14. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
[TBL] [Abstract][Full Text] [Related]
16. Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus.
Riad A; Unger D; Du J; Westermann D; Mohr Z; Sobirey M; Dorenkamp M; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2007 Jan; 554(1):40-5. PubMed ID: 17097634
[TBL] [Abstract][Full Text] [Related]
17. The novel P2Y 12 antagonist AZD6140 rapidly and reversibly reduces platelet activation in diabetic rats.
Flierl U; Schöpp C; Jaitner J; Bauersachs J; Schäfer A
Thromb Res; 2010 Mar; 125(3):e93-9. PubMed ID: 19846210
[TBL] [Abstract][Full Text] [Related]
18. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
Ii M; Nishimura H; Kusano KF; Qin G; Yoon YS; Wecker A; Asahara T; Losordo DW
Circulation; 2005 Jul; 112(1):93-102. PubMed ID: 15983249
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin improves diabetes-induced coronary endothelial dysfunction.
Tawfik HE; El-Remessy AB; Matragoon S; Ma G; Caldwell RB; Caldwell RW
J Pharmacol Exp Ther; 2006 Oct; 319(1):386-95. PubMed ID: 16849625
[TBL] [Abstract][Full Text] [Related]
20. Changes of macrovascular endothelial ultrastructure and gene expression of endothelial nitric oxide synthase in diabetic rats.
Lu YL; Hu SJ; Shen ZJ; Shao YC
Chin Med J (Engl); 2004 Aug; 117(8):1165-9. PubMed ID: 15361289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
